ClinicalTrials.Veeva

Menu

Transfusion Ratio of Fresh Frozen Plasma (FFP) to Packed Red Blood Cell (PRBC) During Burn Excision and Grafting

S

Shriners Hospitals for Children

Status

Completed

Conditions

Burn Injury

Treatments

Other: Treatment

Study type

Interventional

Funder types

Other

Identifiers

NCT05063409
SHC 70014
216586 (Other Identifier)

Details and patient eligibility

About

The purpose of this study is to determine if burn injured patients who receive blood transfusions in the operating room have better outcomes when given transfusions at a set ratio (1:1)of PRBC to FFP.

Traditionally, patients that need blood transfusions during surgery are given mostly packed red blood cells (PRBC) and some fresh frozen plasma (FFP). This is usually about 1:4 ratio of FFP to PRBC.

In this study, we will compare this traditional approach (1:4) to a 1:1 ratio of FFP to PRBC during the operative period.

The hypothesis of the study is that the use of FFP/PRBC ratio of 1:1, compared to a ratio of 1:4 will result in a(n)

  1. decrease in the amount of blood transfused in the operating room
  2. decrease in the amount of blood transfused during hospitalization
  3. improvement in coagulation parameters (PT/PTT, INR, antithrombin III, Protein C and Fibrinogen in the operative period (from operation start to 12 hours post operatively) and at 24 hours postoperatively
  4. decrease the hospital length of stay, lung dysfunction, infections, and mortality

Full description

The hypothesis of the study is that the use of a fresh frozen plasma/packed red blood cells (FFP/PRBC) ratio of 1:1, compared to a ratio of 1:4 during operative excision of >20% TBSA will: result in a decrease in the amount of blood transfused in the operating room, a decrease in the amount of blood transfused during hospitalization, an improvement in coagulation parameters (PT/PTT, INR) in the operative period (from operation start to 12 hours postoperatively) and at 24 hours postoperatively, and a decrease in hospital length of stay, lung dysfunction, number of infections, and mortality.

The primary objective of the study is to determine if aggressive correction of intraoperative coagulopathy during burn excision and grafting results in improved outcomes.

Enrollment

72 patients

Sex

All

Ages

1 month to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient is 1 month to </= 18 yrs of age
  • Admitted to Shriners Hospitals for Children Northern California
  • Patient has a third degree burn >/= 20 % total body surface area (TBSA)

Exclusion criteria

  • Infants < 5 kg

  • Pregnancy

    • 18 years of age
  • Inability or unwillingness to receive blood products

  • Pre-existing need for hemodialysis

  • Brain death or imminent brain death

  • Non-survivable burn as determined by the attending burn surgeon

  • Pre-existing hematologic disease

  • Closed head injury with Glasgow Coma Score <9

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

72 participants in 2 patient groups

1:1 Ratio of FFP to PRBC
Active Comparator group
Description:
Randomized treatment to receive blood products at a ratio of 1:1 FFP to PRBC during the operative period (start of surgery to 12 hours post operatively)
Treatment:
Other: Treatment
1:4 Ratio FFP to PRBC
Active Comparator group
Description:
Randomized treatment to receive blood products at a ratio of 1:4 FFP to PRBC during the operative period (start of surgery to 12 hours post operatively)
Treatment:
Other: Treatment

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems